Fig. 2. MiR-155 and sGCβ1 are differentially expressed in HFD-fed ApoE^−/− mice and atherosclerotic and preeclamptic patients.

a The miR-155 levels in sera from atherosclerotic patients and healthy controls were assessed by qRT-PCR (n = 11 per group). b, c The levels of miR-155 and sGCβ1 protein were determined in aortic vessels of ApoE^−/− mice fed a HFD or a chow diet by qRT-PCR and Western blotting (n = 6 per group). d The miR-155 levels in sera and placental vessels from healthy pregnant (HP) women and preeclamptic patients (PE) were determined (n = 10 per group). e The sGCα1 and sGCβ1 mRNA levels in placental vessels from healthy pregnant women and preeclamptic patients were analyzed by RT-PCR (n = 10 per group). **P < 0.01